Indaptus Therapeutics, Inc. - Common Stock, $0.01 par value (INDP)
CUSIP: 45339J105
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, $0.01 par value
- Shares outstanding
- 111,087,302
- Total 13F shares
- 605,020
- Share change
- +5,105
- Total reported value
- $750,238
- Price per share
- $1.24
- Number of holders
- 17
- Value change
- +$5,985
- Number of buys
- 5
- Number of sells
- 8
Quarterly Holders Quick Answers
What is CUSIP 45339J105?
CUSIP 45339J105 identifies INDP - Indaptus Therapeutics, Inc. - Common Stock, $0.01 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45339J105:
Institutional Holders of Indaptus Therapeutics, Inc. - Common Stock, $0.01 par value (INDP) as of Q3 2024
As of 30 Sep 2024,
Indaptus Therapeutics, Inc. - Common Stock, $0.01 par value (INDP) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
605,020 shares.
The largest 10 holders included
VANGUARD GROUP INC, INVESTMENT HOUSE LLC, GEODE CAPITAL MANAGEMENT, LLC, STRATEGY ASSET MANAGERS LLC, Pine Valley Investments Ltd Liability Co, RENAISSANCE TECHNOLOGIES LLC, Vivaldi Capital Management LP, CITADEL ADVISORS LLC, STATE STREET CORP, and Tower Research Capital LLC (TRC).
This page lists
18
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
21
Q3 2024 holders
17
Holder diff
-4
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.